ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
IssuerBlackrock
ETF TickerBTEE(USD) LSE
ETF TickerBTEE.L(GBP) LSE

Holdings detail for FATE

Stock NameFate Therapeutics Inc
TickerFATE(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS31189P1021
LEI549300L14Q4UHOODLA90

Show aggregate FATE holdings

News associated with FATE

Fate Therapeutics (NASDAQ:FATE) & Cyclerion Therapeutics (NASDAQ:CYCN) Head-To-Head Analysis
Fate Therapeutics (NASDAQ:FATE – Get Free Report) and Cyclerion Therapeutics (NASDAQ:CYCN – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, valuation and earnings. Risk & Volatility Fate Therapeutics has a […] - 2025-08-29 02:14:49
Brokerages Set Fate Therapeutics, Inc. (NASDAQ:FATE) Price Target at $3.83
Shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report) have been assigned an average rating of “Hold” from the eight ratings firms that are covering the company, Marketbeat reports. Seven equities research analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 1 […] - 2025-06-24 02:54:47
Squarepoint Ops LLC Purchases 20,805 Shares of Fate Therapeutics, Inc. (NASDAQ:FATE)
Squarepoint Ops LLC grew its position in shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 154.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 34,295 shares of the biopharmaceutical company’s stock after acquiring an additional 20,805 […] - 2025-06-11 05:08:50
Bank of America Corp DE Reduces Position in Fate Therapeutics, Inc. (NASDAQ:FATE)
Bank of America Corp DE lessened its holdings in shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 64.4% in the 4th quarter, Holdings Channel reports. The institutional investor owned 304,129 shares of the biopharmaceutical company’s stock after selling 550,066 shares during the quarter. Bank of America Corp DE’s holdings in Fate Therapeutics were […] - 2025-06-11 04:14:58
Graham Capital Management L.P. Buys New Shares in Fate Therapeutics, Inc. (NASDAQ:FATE)
Graham Capital Management L.P. bought a new stake in shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 22,342 shares of the biopharmaceutical company’s stock, valued at approximately $37,000. Other large investors […] - 2025-05-20 05:40:49
D. E. Shaw & Co. Inc. Decreases Position in Fate Therapeutics, Inc. (NASDAQ:FATE)
D. E. Shaw & Co. Inc. lessened its holdings in shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 54.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,536,633 shares of the biopharmaceutical company’s stock after selling 1,841,017 shares […] - 2025-05-20 04:56:58
Hsbc Holdings PLC Has $179,000 Stock Holdings in Fate Therapeutics, Inc. (NASDAQ:FATE)
Hsbc Holdings PLC grew its stake in Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 22.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 109,422 shares of the biopharmaceutical company’s stock after purchasing an additional 19,706 shares during the quarter. Hsbc […] - 2025-05-12 04:56:49
Fate Therapeutics, Inc. (NASDAQ:FATE) Receives $5.43 Consensus PT from Analysts
Shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report) have been given a consensus rating of “Hold” by the nine research firms that are presently covering the firm, Marketbeat reports. Seven equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average […] - 2025-05-05 03:13:09
CANADA LIFE ASSURANCE Co Has $35,000 Stock Position in Fate Therapeutics, Inc. (NASDAQ:FATE)
CANADA LIFE ASSURANCE Co trimmed its position in Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 53.4% in the fourth quarter, Holdings Channel.com reports. The firm owned 21,267 shares of the biopharmaceutical company’s stock after selling 24,365 shares during the period. CANADA LIFE ASSURANCE Co’s holdings in Fate Therapeutics were worth $35,000 at the end […] - 2025-05-01 05:50:46
Marshall Wace LLP Makes New Investment in Fate Therapeutics, Inc. (NASDAQ:FATE)
Marshall Wace LLP bought a new position in shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 512,641 shares of the biopharmaceutical company’s stock, valued at approximately $846,000. Marshall Wace LLP owned approximately 0.45% of Fate […] - 2025-05-01 04:53:01
Cerity Partners LLC Grows Holdings in Fate Therapeutics, Inc. (NASDAQ:FATE)
Cerity Partners LLC boosted its holdings in shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 4,953.6% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 823,134 shares of the biopharmaceutical company’s stock after purchasing an additional 806,846 shares during the period. Cerity Partners LLC owned […] - 2025-04-18 05:06:56
Fate Therapeutics, Inc. (NASDAQ:FATE) Shares Sold by Prudential Financial Inc.
Prudential Financial Inc. trimmed its position in shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) by 9.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 321,401 shares of the biopharmaceutical company’s stock after selling 35,200 shares during the […] - 2025-04-09 04:51:00
Fate Therapeutics (NASDAQ:FATE) Lowered to “Sell” Rating by StockNews.com
StockNews.com cut shares of Fate Therapeutics (NASDAQ:FATE – Free Report) from a hold rating to a sell rating in a research note issued to investors on Tuesday. FATE has been the topic of a number of other reports. Stifel Nicolaus cut their target price on Fate Therapeutics from $5.00 to $3.00 and set a “hold” […] - 2025-03-12 04:42:57
Fate Therapeutics (NASDAQ:FATE) Upgraded by StockNews.com to Hold Rating
Fate Therapeutics (NASDAQ:FATE – Get Free Report) was upgraded by investment analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued to investors on Monday. A number of other research firms have also issued reports on FATE. Wedbush reaffirmed a “neutral” rating and set a $5.00 target price on […] - 2025-03-05 04:52:57

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) FATE holdings

DateNumber of FATE Shares HeldBase Market Value of FATE SharesLocal Market Value of FATE SharesChange in FATE Shares HeldChange in FATE Base ValueCurrent Price per FATE Share HeldPrevious Price per FATE Share Held
2025-12-03 (Wednesday)76,018USD 82,099FATE holding increased by 5701USD 82,0990USD 5,701 USD 1.07999 USD 1.005
2025-12-02 (Tuesday)76,018FATE holding increased by 2835USD 76,398FATE holding increased by 1020USD 76,3982,835USD 1,020 USD 1.005 USD 1.02999
2025-12-01 (Monday)73,183USD 75,378FATE holding decreased by -8051USD 75,3780USD -8,051 USD 1.02999 USD 1.14001
2025-11-28 (Friday)73,183FATE holding increased by 189USD 83,429FATE holding increased by 3136USD 83,429189USD 3,136 USD 1.14001 USD 1.09999
2025-11-27 (Thursday)72,994USD 80,293USD 80,2930USD 0 USD 1.09999 USD 1.09999
2025-11-26 (Wednesday)72,994FATE holding increased by 567USD 80,293FATE holding increased by 3520USD 80,293567USD 3,520 USD 1.09999 USD 1.06001
2025-11-25 (Tuesday)72,427FATE holding increased by 945USD 76,773FATE holding decreased by -428USD 76,773945USD -428 USD 1.06001 USD 1.08001
2025-11-24 (Monday)71,482FATE holding increased by 189USD 77,201FATE holding increased by 3769USD 77,201189USD 3,769 USD 1.08001 USD 1.03
2025-11-21 (Friday)71,293USD 73,432FATE holding increased by 2139USD 73,4320USD 2,139 USD 1.03 USD 1
2025-11-20 (Thursday)71,293FATE holding decreased by -756USD 71,293FATE holding decreased by -4358USD 71,293-756USD -4,358 USD 1 USD 1.04999
2025-11-19 (Wednesday)72,049FATE holding increased by 189USD 75,651FATE holding increased by 2354USD 75,651189USD 2,354 USD 1.04999 USD 1.02
2025-11-18 (Tuesday)71,860FATE holding increased by 1134USD 73,297FATE holding increased by 4481USD 73,2971,134USD 4,481 USD 1.02 USD 0.972994
2025-11-17 (Monday)70,726FATE holding increased by 378USD 68,816FATE holding increased by 1001USD 68,816378USD 1,001 USD 0.972994 USD 0.963993
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of FATE by Blackrock for IE00BDZVHG35

Show aggregate share trades of FATE

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-02BUY2,8351.0601.000 1.006USD 2,852 1.17
2025-11-28BUY1891.1531.100 1.105USD 209 1.17
2025-11-26BUY5671.1001.050 1.055USD 598 1.17
2025-11-26BUY5671.1001.050 1.055USD 598 1.17
2025-11-25BUY9451.1301.040 1.049USD 991 1.17
2025-11-24BUY1891.1001.050 1.055USD 199 1.17
2025-11-20SELL-7561.1050.994 1.005USD -760 1.18 Profit of 129 on sale
2025-11-19BUY1891.0700.980 0.989USD 187 1.18
2025-11-18BUY1,1341.0300.961 0.968USD 1,097 1.18
2025-11-17BUY3781.0600.960 0.970USD 367 1.18
2025-11-14BUY1891.0450.950 0.959USD 181 1.18
2025-11-12BUY1871.1551.030 1.042USD 195 1.18
2025-11-10BUY1871.1201.050 1.057USD 198 1.18
2025-11-06BUY1871.1401.030 1.041USD 195 1.18
2025-11-04BUY1871.3001.185 1.196USD 224 1.19
2025-10-30BUY9351.3801.280 1.290USD 1,206 1.18
2025-10-29BUY3741.3401.487 1.472USD 551 1.18
2025-10-22SELL-7481.4901.580 1.571USD -1,175 1.17 Loss of -301 on sale
2025-10-20BUY3741.5401.560 1.558USD 583 1.16
2025-10-17BUY9311.4701.530 1.524USD 1,419 1.16
2025-10-15BUY1,4721.5301.530 1.530USD 2,252 1.16
2025-10-03BUY1,3091.2101.230 1.228USD 1,607 1.16
2025-10-02BUY1871.2101.250 1.246USD 233 1.16
2025-10-01BUY3741.2501.370 1.358USD 508 1.15
2025-09-26BUY3741.0001.010 1.009USD 377 1.16
2025-09-25BUY3720.9701.000 0.997USD 371 1.16
2025-09-18BUY1861.0001.020 1.018USD 189 1.16
2025-09-17BUY5580.9501.010 1.004USD 560 1.16
2025-07-17SELL-3741.1501.180 1.177USD -440 1.16 Loss of -5 on sale
2025-07-11SELL-1,4961.1501.170 1.168USD -1,747 1.16 Loss of -7 on sale
2025-07-02BUY10,1751.1201.220 1.210USD 12,312 1.16
2025-06-25BUY3701.1601.200 1.196USD 443 1.17
2025-06-11BUY3701.5501.740 1.721USD 637 1.16
2025-06-10BUY3701.6701.820 1.805USD 668 1.15
2025-06-04SELL-1851.4201.450 1.447USD -268 1.14 Loss of -57 on sale
2025-04-23BUY1851.3301.490 1.474USD 273 1.12
2025-04-10SELL-1,4880.9400.960 0.958USD -1,426 1.12 Profit of 243 on sale
2025-04-08SELL-3720.9100.990 0.982USD -365 1.13 Profit of 55 on sale
2025-04-04SELL-9300.7500.760 0.759USD -706 1.14 Profit of 356 on sale
2025-04-01BUY7440.7600.800 0.796USD 592 1.16
2025-03-31SELL-5580.7900.830 0.826USD -461 1.17 Profit of 189 on sale
2025-03-14SELL-2,9760.9400.970 0.967USD -2,878 1.24 Profit of 822 on sale
2025-03-07SELL-3721.0101.060 1.055USD -392 1.29 Profit of 86 on sale
2025-03-04SELL-1860.9501.010 1.004USD -187 1.32 Profit of 59 on sale
2025-02-25BUY3721.2301.370 1.356USD 504 1.36
2025-02-19SELL-1861.7101.810 1.800USD -335 1.33 Loss of -87 on sale
2025-02-13BUY5581.2701.280 1.279USD 714 1.31
2025-02-12BUY1861.2501.260 1.259USD 234 1.32
2025-02-11BUY7441.2101.250 1.246USD 927 1.33
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of FATE

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19373,9800796,62446.9%
2025-09-18183,2590872,79321.0%
2025-09-17380,1411,298911,79841.7%
2025-09-16176,2712,009486,90436.2%
2025-09-15413,5580746,43555.4%
2025-09-12435,1853,037892,41948.8%
2025-09-11325,3200794,40841.0%
2025-09-10491,44840,6041,057,89346.5%
2025-09-09365,2042861,03042.4%
2025-09-08404,61428,783706,45257.3%
2025-09-05511,9468271,114,79145.9%
2025-09-04531,65201,051,49150.6%
2025-09-03275,6390672,39441.0%
2025-09-02186,1410460,22140.4%
2025-08-29173,090280514,78233.6%
2025-08-28182,8752,388422,90043.2%
2025-08-27167,477500398,70942.0%
2025-08-26199,0660566,03435.2%
2025-08-25446,38901,576,49628.3%
2025-08-22304,7410838,35936.3%
2025-08-21164,7630446,89536.9%
2025-08-20122,1507,328433,46228.2%
2025-08-19761,85354,7971,125,32367.7%
2025-08-18343,38350830,46241.3%
2025-08-15430,7185,432961,48744.8%
2025-08-14343,20001,047,92932.8%
2025-08-131,529,52127,5563,479,75744.0%
2025-08-12208,9130528,29039.5%
2025-08-11163,2810458,85935.6%
2025-08-08442,98927,569907,52648.8%
2025-08-07466,27928,301904,78751.5%
2025-08-06228,2261,411452,05350.5%
2025-08-05237,3450577,19941.1%
2025-08-04137,4595487,80228.2%
2025-08-01119,0520419,81428.4%
2025-07-31213,3211,190501,16242.6%
2025-07-30143,87210,418696,73120.6%
2025-07-29244,2539,0761,097,12022.3%
2025-07-28244,58510,7601,146,96921.3%
2025-07-25189,9540546,22234.8%
2025-07-24362,21701,063,60134.1%
2025-07-23213,1025881,464,75614.5%
2025-07-22405,37419,2701,962,87520.7%
2025-07-21100,695148560,90218.0%
2025-07-1893,0470611,17615.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy